Abstract

Introduction and Aim: Acute Kidney Injury (AKI) is a common medical problem, especially in neonatal intensive care unit. However, the reported incidences and associated risk factors are widely heterogenous and sometimes absent for developing countries. Thus, the current work designed to explore the incidence and potential risk factors of AKI for critically ill neonates.
 Patients and methods: The current work was an observational prospective study, completed between March 2019 and March 2022. It included 459 newborns admitted to the NICUs at Al-Azhar University Hospital (New Damietta) and Damietta General Hospital (Ministry of Health, Damietta, Egypt). For all neonates, careful history and clinical examination were done and data was documented. Then, repeated creatinine measurements and arterial blood gas analysis were performed. Discharge or death was the primary end point of the study. Other comorbid conditions were the secondary outcome.
 Results: The incidence of AKI was 92.2% and there was no significant difference between AKI and non-AKI regarding neonatal age, sex and mode of delivery. Patients with AKI had significantly lower gestational age, reduced birth weight, pH and HCO3. The serum creatinine showed significant increase during the first week of NICU admission in AKI than non-AKI groups, while basal values did not. Sepsis, nephrotoxic medications, hypoxic ischemic encephalopathy, umbilical catheter, duration of admission and mortality, all were significantly higher in AKI than non-AKI groups. Sepsis was reported among 44.8% and 27.7%, while mortality was reported for 20.9% and 4.9% of AKI and non-AKI groups, respectively. The duration of admission was 15.25±3.19 vs 9.50±2.21 days respectively.
 Conclusion: AKI was relatively higher (29.2% of admitted neonates) and associated with prematurity and lower birth weight. Neonatal sepsis and exposure to nephrotoxic drugs were among the commonest predisposing factors for AKI.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call